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INTRODUCTION
Human African Trypanosomiasis (HAT),
or sleeping sickness, is a neglected trop-
ical parasitic disease of humans due to
trypanosomes transmitted by tsetse flies
(Glossina spp.) in sub-Saharan Africa.
Comparable diseases (Animal African
Trypanosomiasis—AAT—nagana) are
present in domesticated animals and these
are an important constraint to animal
health and production in Africa (Jordan,
1986; Kabayo, 2002). For HAT, there is
no vaccine, no chemoprophylaxis, and
treatment is still long and difficult to
administer despite recent improvements
(Simarro et al., 2012). In most cases HAT
is fatal if untreated. The disease affects
rural communities in remote parts of
Africa, particularly people working out-
doors (e.g., farmers, foresters, fishermen,
people collecting water) and hence at
greater risk of being bitten by tsetse. Two
flagellate protozoan parasites cause HAT.
Trypanosoma brucei rhodesiense causes the
rhodesiense form of the disease (currently
<5% of all cases) in eastern and south-
ern Africa, and T. b. gambiense causes the
gambiense form of the disease (currently
>95% of all cases) in Central and West
Africa (Simarro et al., 2010).
Although it is accepted that tsetse con-
trol plays a central role in combatting the
rhodesiense form of HAT (Welburn et al.,
2009), this has not been the case for the
gambiense form. Indeed in the strategy rec-
ommended by WHO to control sleeping
sickness, active case detection and treat-
ment has always been the first, it not
the only method recommended, until very
recently. Historically, there have been two
clear justifications for this—(1) that vector
control is not required and/or that (2) it is
too expensive and difficult to organize; we
will discuss both.
IS VECTOR CONTROL REQUIRED IN
GAMBIENSE HAT CONTROL?
First, we would like to make it clear
that we recognize that active case detec-
tion and treatment has proved effective in
HAT control in many foci and that it is
a necessary intervention if those infected
are not to die. However, there are sev-
eral foci where active case detection and
treatment without vector control, despite
saving many lives, has failed to bring
HAT under effective control. Artzrouni
and Gouteux (1996) developed a mathe-
matical model of the basic Reproductive
Number (R0) to analyse and compare vec-
tor control and active case detection and
treatment in the control of gambienseHAT
(see also Gouteux and Artzrouni, 1996).
They showed that when transmission rates
are high (strongly influenced by fly bit-
ing rates on humans) vector control is a
requirement. The model was able to pre-
dict the failure of case detection and treat-
ment and the need for the addition of
vector control before control was achieved
in the well-studied HAT focus of Niari,
Congo Brazzaville. It is quite possible that
the problem in other HAT foci which have
proven intractable by active case detection
and treatment may be explained in the
same way. Such examples can be found in
mangrove foci of Guinea, or humid savan-
nahs in Chad, for instance.
The very earliest campaigns based
on active case detection and treatment
also incorporated interventions against
the fly. The mobile teams of Jamot,
Richet, and others who controlled HAT
in francophone Africa, used the famous
“prophylaxis agronomy” strategy to com-
plete the medical activities. This strat-
egy aimed to destroy the natural habitat
of tsetse in order to reduce vector-borne
transmission of T. b. gambiense. Although
not acceptable today because of obvious
environmental concerns, it is noteworthy
that the principle of combining vector
control and medical activities to eliminate
T. b. gambiensewas understood a long time
ago.
Recent advances in our understand-
ing of the epidemiology of Gambian HAT
have strengthened the case for an inte-
grated approach. First, mature T. b. gam-
biense infection rates in tsetse (i.e., when
trypanosomes have reached the salivary
glands of tsetse and can be transmitted
to the next mammalian host) are usually
below 1% even in active foci (Jamonneau
et al., 2004), and this is also true for
T. b. rhodesiense (Auti et al., 2012). This
means that reduction in tsetse densities,
even those not reaching total elimination,
will also reduce transmission. Re-analysis
of the theoretical models developed by
Artzrouni and Gouteux (1996) suggest
that transmission can be halted without
the elimination of tsetse (Hastings, unpub-
lished data).
Second, there is more and more evi-
dence that some people can live a long time
while being infected by T. b. gambiense
(Bucheton et al., 2011; Jamonneau et al.,
2012). This is the case for asymptomatic
carriers, but also for some seropositive
people who are not detected by the
parasitological techniques and who will
develop the disease (Bucheton et al., 2011).
These two elements strongly suggest
that without vector control to break
the transmission cycle, elimination of
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T. b. gambiense cannot be achieved even
under the assumption that HAT is an
anthroponosis (i.e., transmission does
not involve a non-human reservoir host).
If non-humans are important reservoir
hosts (Funk et al., 2013), then, as with
Rhodesian HAT, elimination of Gambian
HAT can only be achieved through a com-
bination of medical activities and vector
control.
In addition to the technical arguments,
tsetse control may make active case detec-
tion and treatment more efficient and
affordable. Active case detection and treat-
ment rarely covers more than 80% of the
community treated. And it is recognized
that the people who are not screened are
the ones who are the most exposed (farm-
ers, fishermen, hunters, people who work
in plantations): Laveissière and Penchenier
(2005) estimate that when 75% of the total
population is attending a HAT medical
survey, only 50% of the cases are detected.
As a result, transmission of T. b. gambiense
will still continue after a medical interven-
tion unless vector control is also carried
out. In the absence of a vaccine or prophy-
lactic drugs, vector control offers the only
means of protecting people from infec-
tion while also reducing transmission of
trypanosomes from the residual popula-
tion of HAT-infected people. We suggest
therefore that adding a vector control
component will increase the sustainability
of medical interventions.
IS VECTOR CONTROL AFFORDABLE
AND ACHIEVABLE?
Restricted application of insecticide to cat-
tle has proved cost effective and success-
ful (Torr et al., 2007) and this technique
currently provides good control of rhode-
siense form HAT in Uganda (Welburn
et al., 2006) and so has proved affordable
and achievable. However, this approach
to HAT control only works where cattle
densities are high enough, which is not
the case for most areas with gambiense
HAT. Where cattle densities are not high
enough, insecticide treated cloth targets
or cloth traps are often used and have
been used successfully (Lancien, 1991;
Laveissière and Penchenier, 2005) and cur-
rently tsetse control operations conducted
in Gambian HAT foci use this type of tech-
nology (Kagbadouno et al., 2011, 2012).
In all situations, the vector control phase
should be implemented after a first phase
of baseline data collection that will help
to precisely define the identity, density,
and spatial distribution of the targeted
tsetse species. Until recently, tsetse control
operations have been said to be unafford-
able, however recent work has changed this
(Lindh et al., 2009; Rayaisse et al., 2010;
Esterhuizen et al., 2011). Thismore afford-
able means of vector control is discussed
below.
Most gambiense-HAT is transmitted by
“Palpalis group” tsetse, more commonly
known as riverine tsetse. If we look more
closely at the known distribution of HAT
cases and the distribution of tsetse flies,
we can see that the vast majority of cur-
rent transmission is being caused by only
two tsetse species, G. fuscipes spp. and
G. palpalis spp. We have been concen-
trating on producing cheaper, target-based
control technology for these species with
funding from the Bill and Melinda Gates
Foundation. A major discovery is that
very small targets (see Figure 1) are highly
effective for these two species (Rayaisse
et al., 2010; Esterhuizen et al., 2011).
This completely changes the prospects for
use of tsetse control in campaigns against
gambiense form HAT. Commercial com-
panies can provide long-lasting versions
of these insecticide impregnated targets
at ∼$1 each. Reducing target size will
not only reduce material costs but also
promises significant savings in operational
costs. The large size of standard target
designs means deployment is difficult and
FIGURE 1 | Picture of a recently developed insecticide impregnated tiny target deployed on
the bank of a river in a forest gallery.
slow. Shaw et al., 2007, using data from
control operations conducted using large
targets, estimated that the overall mean
rate of deployment was one target per
person per day. We believe that the tiny
targets now available will increase deploy-
ment rates considerably and the savings
associated with this increased productivity
will be significant. Once deployment rates
reach >4 targets per person per day we
estimate the costs fall to between US$50
to 100 per km2 per year which makes vec-
tor control a more feasible proposition for
those involved in HAT control.
WHO SHOULD DO THE CONTROL?
Tsetse control can be effectively under-
taken at a range of levels from regional
activities involving several countries to
the local village level. A possible scenario
could be that control activities should be
planned, organized, and implemented at
the scale of the focus, by national HAT
control programs with personnel from
health or vector control structures who
already work in the focus. Clearly at the
beginning, baseline data collection and
the first vector control activities should
be organized professionally by a national
team who has the expertise of doing it,
or who has been trained to have such
expertise. Then, most of the activities (tar-
get maintenance, deployment, and tsetse
densities monitoring) could be progres-
sively transferred to NGOs or local health
workers, with some supervision from the
national team.
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CONCLUSION
A change of paradigm has occurred, since
it is now recognized that vector control is
part of the elimination strategy of gambi-
ense HAT (WHO, 2012), as a complement
to medical activities. Integrating medi-
cal and vector-based interventions will
enable HAT-affected countries to elimi-
nate Gambian HAT.
ACKNOWLEDGMENTS
Our work on new targets has been funded
by the Bill and Melinda Gates Foundation.
REFERENCES
Artzrouni, M., and Gouteux, J. P. (1996). Control
strategies for sleeping sickness in Central Africa:
a model-based approach. Trop. Med. Int. Health
1, 753–764. doi: 10.1111/j.1365-3156.1996.
tb00107.x
Auti, H., Picozzi, K., Malele, I., Torr, S. J., Cleaveland,
S., and Welburn, S. C. (2012). Using molecular
data for epidemiological inference: assessing the
prevalence of Trypanosoma brucei rhodesiense in
tsetse in Serengeti, Tanzania. PLoS Negl. Trop. Dis.
6:e1501. doi: 10.1371/journal.pntd.0001501
Bucheton, B., MacLeod, A., and Jamonneau, V.
(2011). Human host determinants influencing
the outcome of Trypanosoma brucei gambiense
infections. Parasite Immunol. 33, 438–447. doi:
10.1111/j.1365-3024.2011.01287.x
Esterhuizen, J., Rayaisse, J. B., Tirados, I., Mpiana, S.,
Solano, P., Vale, G. A., et al. (2011). Improving
the cost-effectiveness of visual devices for the con-
trol of riverine tsetse flies, the major vectors of
Human African Trypanosomiasis. PLoS Negl. Trop.
Dis. 5:e1257. doi: 10.1371/journal.pntd.0001257
Funk, S., Nishiura, H., Heesterbeek, H., Edmunds,
W. J., and Cecchi, F. (2013). Identifying
transmission cycles at the human-animal
interface: the role of animal reservoirs in
maintaining Gambiense Human African
Trypanosomiasis. PLoS Comput. Biol. 9:e1002855.
doi: 10.1371/journal.pcbi.1002855
Gouteux, J. P., and Artzrouni, M. (1996). Is vec-
tor control needed in the fight against sleeping
sickness. A biomathematical approach. Bull. Soc.
Pathol. Exot. 89, 299–305.
Jamonneau, V., Ilboudo, H., Kaboré, J., Kaba, D.,
Koffi, M., Solano, P., et al. (2012). Untreated
human infections by Trypanosoma brucei gam-
biense are not 100% fatal. PLoS Negl. Trop. Dis.
6:e1691. doi: 10.1371/journal.pntd.0001691
Jamonneau, V., Ravel, S., Koffi, M., Zeze, D., Kaba, D.,
N’Dri, L., et al. (2004). Mixed trypanosome infec-
tions in tsetse and pigs and their epidemiological
significance in a sleeping sickness focus in Côte
d’Ivoire. Parasitology 129, 693–702.
Jordan, A. M. (1986). Trypanosomiasis Control and
African Rural Development. London: Longman.
Kabayo, J. P. (2002). Aiming to eliminate tsetse
from Africa. Trends Parasitol. 18, 473–475. doi:
10.1016/S1471-4922(02)02371-1
Kagbadouno, M., Camara, M., Bouyer, J., Courtin,
F., Morifaso, O., and Solano, P. (2011). Progress
towards the eradication of tsetse from Loos islands,
Guinea. Parasit. Vectors 4, 18. doi: 10.1186/1756-
3305-4-18
Kagbadouno, M., Camara, M., Rouamba, J.,
Traoré, I. S., Rayaisse, J. B., Camara, O.,
et al. (2012). Epidemiology of sleeping
sickness in Boffa (Guinea): where are the try-
panosomes. PLoS Negl. Trop. Dis. 6:e1949. doi:
10.1371/journal.pntd.0001949
Lancien, J. (1991). Controlling sleeping sickness in
southeastern Uganda with tsetse-fly traps. Ann.
Soc. Belg. Med. Trop. 71, 35–47.
Laveissière, C., and Penchenier, L. (2005). Manuel de
Lutte Contre la Maladie du Sommeil. Paris: IRD
Editions.
Lindh, J. M., Torr, S. J., Vale, G. A., and Lehane,
M. J. (2009). Improving the cost-effectiveness of
artificial visual baits for controlling the tsetse fly
Glossina fuscipes fuscipes. PLoS Negl. Trop. Dis.
3:e474. doi: 10.1371/journal.pntd.0000474
Rayaisse, J. B., Tirados, I., Kaba, D., Dewhirst,
S., Logan, J., Diarrassouba, A., et al. (2010).
Prospects for odour bait development to control
vectors of Trypanosomiasis in West Africa, the
tsetse flies Glossina tachinoides and G. palpalis s.l.
PLoS Negl. Trop. Dis. 4:e632. doi: 10.1371/jour-
nal.pntd.0000632
Shaw, A., Torr, S., Waiswa, C., and Robinson, T. P.
(2007). “Comparative costings of alternatives for
dealing with tsetse: Estimates for Uganda,” in FAO
Pro-Poor Livestock Policy Initiative Working Paper,
no. 40, (Rome). Available online at: http://www.
fao.org/ag/againfo/programmes/en/pplpi/docarc/
wp40.pdf
Simarro, P. P., Cecchi, G., Paone, M., Franco, J. R.,
Diarra, A., Ruiz, J. A., et al. (2010). The Atlas of
human African trypanosomiasis: a contribution
to global mapping of neglected tropical diseases.
Int. J. Health Geogr. 9, 57. doi: 10.1186/1476-
072X-9-57
Simarro, P. P., Franco, J., Diarra, A., Postigo, J. A.,
and Jannin, J. (2012). Update on field used of
the available drugs for the chemotherapy of
human african trypanosomiasis. Parasitology
139, 842–846. doi: 10.1017/S003118201
2000169
Torr, S. J., Maudlin, I., and Vale, G. A. (2007). Less is
more: restricted application of insecticide to cattle
to improve the cost and efficacy of tsetse control.
Med. Vet. Entomol. 21, 53–64. doi: 10.1111/j.1365-
2915.2006.00657.x
Welburn, S. C., Coleman, P. G., Maudlin, I., Fevre,
E. M., Odiit, M., and Eisler, M. C. (2006).
Crisis, what crisis. Control of Rhodesian sleep-
ing sickness. Trends Parasitol. 22, 123–128. doi:
10.1016/j.pt.2006.01.011
Welburn, S. C., Maudlin, I., and Simarro, P.
P. (2009). Controlling sleeping sickness—
a review. Parasitology 136, 1943–1949. doi:
10.1017/S0031182009006416
WHO. (2012). Report of a WHO Meeting
on Elimination of African Trypanosomiasis
(Trypanosoma brucei gambiense) (Geneva), 80.
Received: 12 June 2013; accepted: 08 July 2013;
published online: 31 July 2013.
Citation: Solano P, Torr SJ and Lehane MJ (2013) Is
vector control needed to eliminate gambiense human
African trypanosomiasis? Front. Cell. Infect. Microbiol.
3:33. doi: 10.3389/fcimb.2013.00033
Copyright © 2013 Solano, Torr and Lehane. This is an
open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is per-
mitted, provided the original author(s) or licensor are
credited and that the original publication in this journal
is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org July 2013 | Volume 3 | Article 33 | 3
